For decades , clinicians have struggled to find effective treatments for treatment-resistant mood disorders. Recently suggests copyright therapy, given typically intravenously , appears to offer real breakthrough for people who haven't benefited from traditional antidepressants . While largely considered an experimental approach , initial research